News &amp; Updates

Artificial intelligence (AI) chatbots, such as ChatGPT, can be used by clinicians as a resource for disease management and education, but researchers of a recent study urge users to consider the “gaps” seen in managing individuals with type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS).

ChatGPT may aid in diabetes, MetS management, but with caveat

07 Nov 2024

Menopausal hormone therapy prevents relapse in women with SSD

Use of menopausal hormone therapy (MHT) can avert psychosis relapse in women with schizophrenia or schizoaffective disorder (SSD) of menopausal age, suggests a recent study.

Menopausal hormone therapy prevents relapse in women with SSD

07 Nov 2024

Lomitapide lowers LDL-C levels in paediatric homozygous familial hypercholesterolaemia

Children with homozygous familial hypercholesterolaemia (HoFH) achieve significant and clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) with the microsomal triglyceride transfer protein (MTP) inhibitor lomitapide, which represents an efficient LDL receptor-independent treatment option, according to the open-label phase III APH-19 trial.

Lomitapide lowers LDL-C levels in paediatric homozygous familial hypercholesterolaemia

Black coffee helps prevent metabolic syndrome in women

Drinking 2 to 3 cups of black coffee daily appears protective against metabolic syndrome (MetS) in women, potentially due to its positive impact on high-density lipoprotein cholesterol (HDL-C) and triglycerides, suggests a Korea study.

Black coffee helps prevent metabolic syndrome in women

Hyperuricaemia linked to short-term readmission, mortality risk in HF

For patients with heart failure (HF), hyperuricaemia is a risk factor for an increase in the risk of short-term hospital readmission and mortality, as reported in a retrospective study.

Hyperuricaemia linked to short-term readmission, mortality risk in HF

Tailored peritoneal dialysis training program cuts infection, dropout rates

A Singapore hospital has pioneered a tailored peritoneal dialysis (PD) training program that has yielded a significant reduction in PD-related infections and dropouts among patients with end-stage kidney disease (ESKD).

Tailored peritoneal dialysis training program cuts infection, dropout rates

05 Nov 2024

Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?

The use of sodium glucose cotransporter-2 (SGLT2) inhibitors nearly halves the risk of all-cause mortality at 3 years in patients with wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) and type 2 diabetes (T2D), findings from an observational study suggest.

Are SGLT2 inhibitors cardioprotective in wild-type ATTR-CM patients?

05 Nov 2024

Electrolyte abnormalities may increase mortality in patients with eating disorders

Electrolyte abnormalities within 1 year of eating disorder diagnosis are associated with an increased risk of all-cause mortality, a population-based study in Canada has shown.

Electrolyte abnormalities may increase mortality in patients with eating disorders

05 Nov 2024

More than 90 percent of HK’s population has CKM syndrome